Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Amphastar Pharmaceuticals, Inc. Director's Dealing 2015

Jun 13, 2015

10216_dirs_2015-06-12_6cd8c8bb-bedb-4c74-bd73-06c842e5671b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Amphastar Pharmaceuticals, Inc. (AMPH)
CIK: 0001297184
Period of Report: 2015-06-05

Reporting Person: Zhang Jack Y. (Director, CEO & Chief Science Officer, 10% Owner)
Reporting Person: Luo Mary Z. (Director, COO, Chief Scientist, Chairman, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-06-05 Common Stock F 4831 $16.4642 Disposed 917306 Direct
2015-06-08 Common Stock F 3046 $16.614 Disposed 914260 Direct
2015-06-09 Common Stock F 2624 $16.2356 Disposed 911636 Direct
2015-06-10 Common Stock M 12975 $12.97 Acquired 924611 Direct
2015-06-10 Common Stock S 11731 $16.3792 Disposed 912880 Direct
2015-06-10 Common Stock F 1244 $16.3792 Disposed 911636 Direct
2015-06-11 Common Stock M 12860 $12.97 Acquired 924496 Direct
2015-06-11 Common Stock S 11600 $16.4694 Disposed 912896 Direct
2015-06-11 Common Stock F 1260 $16.4694 Disposed 911636 Direct
2015-06-12 Common Stock M 83253 $12.97 Acquired 994889 Direct
2015-06-12 Common Stock S 75618 $16.1487 Disposed 919271 Direct
2015-06-12 Common Stock F 7635 $16.1487 Disposed 911636 Direct
2015-06-05 Common Stock F 6173 $16.4657 Disposed 667351 Indirect
2015-06-08 Common Stock F 3052 $16.6087 Disposed 664299 Indirect
2015-06-09 Common Stock F 2633 $16.2339 Disposed 661666 Indirect
2015-06-10 Common Stock M 12619 $12.97 Acquired 674285 Indirect
2015-06-10 Common Stock S 11411 $16.3719 Disposed 662874 Indirect
2015-06-10 Common Stock F 1208 $16.3719 Disposed 661666 Indirect
2015-06-11 Common Stock M 12930 $12.97 Acquired 674596 Indirect
2015-06-11 Common Stock S 11664 $16.4689 Disposed 662932 Indirect
2015-06-11 Common Stock F 1266 $16.4689 Disposed 661666 Indirect
2015-06-12 Common Stock M 42223 $12.97 Acquired 703889 Indirect
2015-06-12 Common Stock S 38471 $16.1673 Disposed 665418 Indirect
2015-06-12 Common Stock F 3752 $16.1673 Disposed 661666 Indirect

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2015-06-10 Employee Stock Option (right to buy) $12.97 M 12975 Disposed 2015-09-28 Common Stock (12975) Direct
2015-06-11 Employee Stock Option (right to buy) $12.97 M 12860 Disposed 2015-09-28 Common Stock (12860) Direct
2015-06-12 Employee Stock Option (right to buy) $12.97 M 83253 Disposed 2015-09-28 Common Stock (83253) Direct
2015-06-10 Employee Stock Option (right to buy) $12.97 M 12619 Disposed 2015-09-28 Common Stock (12619) Indirect
2015-06-11 Employee Stock Option (right to buy) $12.97 M 12930 Disposed 2015-09-28 Common Stock (12930) Indirect
2015-06-12 Employee Stock Option (right to buy) $12.97 M 42223 Disposed 2015-09-28 Common Stock (42223) Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 7631594 Indirect
Common Stock 5000 Indirect
Common Stock 200000 Indirect

Footnotes

F1: The reported securities were withheld to satisfy the Reporting Person's tax liability in connection with a previously reported option exercise.

F2: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the each of the reporting persons on December 16, 2014.

F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.25 to $16.61, inclusive. The reporting persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3), (5), (6), (8), (9) and (10) to this Form 4.

F4: The reported securities were withheld to satisfy the Reporting Person's tax liability in connection with the reported reported option exercise.

F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.38 to $16.62, inclusive.

F6: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.02 to $16.49, inclusive.

F7: The securities are held of record by Mary Z. Luo. The reporting persons are husband and wife.

F8: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.24 to $16.55, inclusive.

F9: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.37 to $16.61, inclusive.

F10: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.03 to $16.39, inclusive.

F11: The shares are held of record by Applied Physics & Chemistry Laboratories, Inc., of which the reporting persons are the sole owners.

F12: The shares are held of record in an account for the benefit of the reporting persons' son. The reporting persons disclaims beneficial ownership of these shares, and the inclusion of these shares in this report should not be deemed an admission of beneficial ownership of any such shares for purposes of Section 16, or for any other purpose.

F13: The shares are held of record by a trust for the benefit of the reporting persons' son. The reporting persons disclaims beneficial ownership of these shares, and the inclusion of these shares in this report should not be deemed an admission of beneficial ownership of any such shares for purposes of Section 16, or for any other purpose.

F14: Shares subject to the option are fully vested and immediately exercisable.